Publications

Journals

• Durrenberger PF; Grünblatt E; Fernando FS; Monoranu CM; Evans J; Riederer P; Reynolds R; Dexter DT. (2012). Inflammatory Pathways in Parkinson's Disease; A BNE Microarray Study. Parkinsons Dis. 2012:214714. DOI.
• Schmitt A; Leonardi-Essmann F; Durrenberger PF; Wichert SP; Spanagel R; Arzberger T; Kretzschmar H; Zink M; et alHerrera-Marschitz M; Reynolds R; Rossner MJ; Falkai P; Gebicke-Haerter PJ. (23 Mar 2012). Structural synaptic elements are differentially regulated in superior temporal cortex of schizophrenia patients. Eur Arch Psychiatry Clin Neurosci. DOI.
• Durrenberger PF; Ettorre A; Kamel F; Webb LV; Sim M; Nicholas RS; Malik O; Reynolds R; et alBoyton RJ; Altmann DM. (2012). Innate immunity in multiple sclerosis white matter lesions: expression of natural cytotoxicity triggering receptor 1 (NCR1). J Neuroinflammation. 9:1. DOI.
• Schmitt A; Leonardi-Essmann F; Durrenberger PF; Parlapani E; Schneider-Axmann T; Spanagel R; Arzberger T; Kretzschmar H; et alHerrera-Marschitz M; Gruber O; Reynolds R; Falkai P; Gebicke-Haerter PJ. (Apr 2011). Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry. 12:201-215. DOI.
• Evans J; Durrenberger PF; Reynolds R; Gruenblatt E; Dexter DT. (15 Sep 2010). Promyelocytic Leukaemia Protein Inclusion Bodies in Parkinsonian Astrocytes. MOVEMENT DISORDERS. 25:S628-S628.
• Durrenberger PF; Fernando S; Kashefi SN; Ferrer I; Hauw JJ; Seilhean D; Smith C; Walker R; et alAl-Sarraj S; Troakes C; Palkovits M; Kasztner M; Huitinga I; Arzberger T; Dexter DT; Kretzschmar H; Reynolds R. (Jan 2010). Effects of antemortem and postmortem variables on human brain mRNA quality: a BrainNet Europe study. J Neuropathol Exp Neurol. 69:70-81. DOI.
• Durrenberger PF; Filiou MD; Moran LB; Michael GJ; Novoselov S; Cheetham ME; Clark P; Pearce RKB; et alGraeber MB. (1 Jan 2009). DnaJB6 Is Present in the Core of Lewy Bodies and Is Highly Up-Regulated in Parkinsonian Astrocytes. JOURNAL OF NEUROSCIENCE RESEARCH. 87:238-245. Author weblink DOI.
• Yiangou Y; Facer P; Durrenberger P; Chessell IP; Naylor A; Bountra C; Banati RR; Anand P. (2006). COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol. 6:12. DOI.
• Durrenberger PF; Facer P; Casula MA; Yiangou Y; Gray RA; Chessell IP; Day NC; Collins SD; et alBingham S; Wilson AW; Elliot D; Birch R; Anand P. (4 Jan 2006). Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: a time-course study. BMC NEUROLOGY. 6. Author weblink DOI.
• Durrenberger PF; Facer P; Gray RA; Chessell IP; Naylor A; Bountra C; Banati RB; Birch R; et alAnand P. (Mar 2004). Cyclooxygenase-2 (Cox-2) in injured human nerve and a rat model of nerve injury. J Peripher Nerv Syst. 9:15-25.

Conferences

• Durrenberger P; Facer P; Casula MA; Prinjha R; Moore S; Woodhams P; Bountra C; Ravid R; et alBirch R; Anand P. Nogo-A and Nogo-66 receptor in multiple sclerosis and amyotrophic lateral sclerosis spinal cord and injured human peripheral nerves. Clinical Neurosciences 2005 Meeting. 77:130-130. (Jan 2006).
• Reynolds R; Magliozzi R; Nicholas R; Roncaroli F; Durrenberger P; Serafini B; Aloisi F; Howell O. Cortical pathology in multiple sclerosis is associated with substantial neurodegeneration and progressive neurological disability. BrainNet Europe 2nd International Conference on Human Brain Tissue Research, 10 Dec 2008 - 12 Dec 2008. 115:1718-1719. SPRINGER WIEN (1 Dec 2008). Author weblink.
• Harris AJ; Durrenberger P; Kamel F; Ettorre A; Nicholas R; Malik O; Altmann DM. Investigating the role of natural killer cell subsets in multiple sclerosis. Annual Congress of the British-Society-for-Immunology, 6 Dec 2010 - 10 Dec 2010. 131:125-125. WILEY-BLACKWELL PUBLISHING, INC (1 Dec 2010). Author weblink.
• Ettorre A; Kamel FO; Durrenberger PF; Traherne J; Giannetti P; Malik O; Nicholas R; Trowsdale J; et alBoyton RJ; Altmann DM. KIR expression as a biomarker of multiple sclerosis disease type. Annual Congress of the British-Society-for-Immunology, 5 Dec 2011 - 8 Dec 2011. 135:172-172. WILEY-BLACKWELL (1 Dec 2011).
• Kamel F; Ettorre A; Durrenberger PF; Malik O; Nicholas R; Boyton R; Altmann D. Altered invariant natural killer T cells in multiple sclerosis. Annual Congress of the British-Society-for-Immunology, 5 Dec 2011 - 8 Dec 2011. 135:41-41. WILEY-BLACKWELL (1 Dec 2011).
• Schmitt A; Falkai PG; Leonardi-Essmann F; Durrenberger PF; Gruber O; Arzberger T; Kretzschmar H; Herrera-Marschitz M; et alReynolds R; Gebicke-Haerter P. DIFFERENTIAL EXPRESSION OF STRUCTURAL SYNAPTIC ELEMENTS IN THE LEFT SUPERIOR TEMPORAL CORTEX OF SCHIZOPHRENIA PATIENTS. 13th International Congress on Schizophrenia Research (ICSR), 2 Apr 2011 - 6 Apr 2011. 37:195-195. OXFORD UNIV PRESS (1 Mar 2011). Author weblink.
• Magliozzi R; Howell OW; Durrenberger PF; Nicholas R; Roncaroli F; Aloisi F; Reynolds R. Cell and molecular changes in the grey matter of secondary progressive multiple sclerosis cases in response to meningeal inflammation. 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, 9 Sep 2009 - 12 Sep 2009. 15:S174-S174. SAGE PUBLICATIONS LTD (1 Sep 2009).
• Durrenberger PF; Fernando S; Kashefi SN; Dexter DT; Reynolds R. Gene expression profiling of grey matter lesions in secondary progressive multiple sclerosis. 13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, 17 Sep 2008 - 20 Sep 2008. 14:S270-S270. SAGE PUBLICATIONS LTD (1 Sep 2008). Author weblink.
• Magliozzi R; Howell OW; Durrenberger PF; Roncacroli F; Nicholas R; Aloisi F; Reynolds R. Substantial neuronal loss and microglia activation in MS grey matter are associated with increased meningeal inflammation. BrainNet Europe 2nd International Conference on Human Brain Tissue Research, 10 Dec 2008 - 12 Dec 2008. 115:1731-1731. SPRINGER WIEN (1 Dec 2008). Author weblink.
• Durrenberger PF; Fernando S; Kashefi SN; Consortium BNE; Dexter DT; Reynolds R. Microarray gene expression analysis of common pathogenetic mechanisms in neurodegenerative diseases. BrainNet Europe 2nd International Conference on Human Brain Tissue Research, 10 Dec 2008 - 12 Dec 2008. 115:1730-1730. SPRINGER WIEN (1 Dec 2008). Author weblink.
• Moran LB; Durrenberger PF; Pearce RKB; Graeber MB. Two new molecular markers of lewy bodies in Parkinson disease. ABN Spring Scientific Meeting 2007, 11 Apr 2007 - 13 Apr 2007. 78:1023-1023. B M J PUBLISHING GROUP (1 Sep 2007). Author weblink.
• Durrenberger PF; Filiou MD; Moran LB; Pearce RKB; Graeber MB. The DnaJ/HSP40 chaperone family: involvement in Parkinson's disease. 108th Annual Meeting of the British-Neuopathological-Society. 33:255-256. (Apr 2007).
• Durrenberger PF; Facer P; Gray RA; Chessell IP; Naylor A; Bountra C; Banati RB; Elliot D; et alAnand P. Increased cyclooxygenase-2 (Cox-2) expression by macrophages in chronic but not acute nerve injury in humans and rodents. Spring Meeting of the Association-of-British-Neurologists, 14 Apr 2004 - 16 Apr 2004. 75:1228-1228. B M J PUBLISHING GROUP (1 Aug 2004). Author weblink.